Related Experiment Video
Updated: Aug 14, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Adrenergic and serotonergic receptor responsiveness in depression
Ciba Foundation Symposium
|January 1, 1986
Summary
Depression impacts noradrenergic and serotonergic systems. Studies show blunted growth hormone responses to clonidine in depressed patients, indicating altered alpha 2-adrenoceptor responsiveness, even in remission.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Depression is associated with dysregulation in neurotransmitter systems, including noradrenergic and serotonergic pathways.
- Abnormalities in noradrenaline release/metabolism and receptor responsiveness are hypothesized in acute depression and remission.
Purpose of the Study:
- To investigate the regulation of noradrenergic and serotonergic systems in acutely depressed patients and those in remission.
- To assess alpha 2-adrenoceptor responsiveness using growth hormone response to clonidine.
- To evaluate prolactin response to fenfluramine, a serotonergic agent, in depressed patients and controls.
Main Methods:
- Measured growth hormone response to clonidine to assess alpha 2-adrenoceptor responsiveness.
- Administered fenfluramine and measured prolactin response to evaluate serotonergic system function.
- Compared responses between acutely depressed patients, patients in remission, and healthy controls.
Main Results:
- Blunted growth hormone responses to clonidine were observed in both acutely depressed patients and patients in remission.
- Preliminary findings suggest a subset of depressed patients may have blunted prolactin responses to fenfluramine.
- No significant difference in fenfluramine-induced prolactin response was found between acute and remitted depression groups, though variability was high.
Conclusions:
- Altered alpha 2-adrenoceptor responsiveness may persist in depression even after remission.
- The serotonergic system might play a contributory role in the pathophysiology of depression.
- Further research is needed to clarify the role of these systems in depression and remission.
More Related Videos
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...